Login / Signup

[Time-limited trials (TLT) in the intensive care unit : Recommendations from the ethics section of the DIVI and the ethics section of the DGIIN].

Susanne JöbgesAnna-Henrikje SeidleinKathrin KnochelAndrej MichalsenGunnar DuttgeAlexander SupadyJochen DutzmannStefan MeierIris BarndtGerald NeitzkeFriedemann NauckAnnette RoggeUwe Janssens
Published in: Medizinische Klinik, Intensivmedizin und Notfallmedizin (2024)
The rise in intensive care treatment procedures is accompanied by an increase in the complexity of decisions regarding the selection, administration and duration of treatment measures. Whether a treatment goal is desirable in an individual case and the treatment plan required to achieve it is acceptable for the patient depends on the patient's preferences, values and life plans. There is often uncertainty as to whether a patient-centered treatment goal can be achieved. The use of a time-limited treatment trial (TLT) as a binding agreement between the intensive care unit (ICU) team and the patient or their legal representative on a treatment concept over a defined period of time in the ICU can be helpful to reduce uncertainties and to ensure the continuation of intensive care measures in the patients' best interest.
Keyphrases
  • intensive care unit
  • public health
  • clinical trial
  • randomized controlled trial
  • case report
  • palliative care
  • chronic kidney disease
  • study protocol
  • open label
  • health insurance